Fovero Therapeutics

Q: What is Fovero Therapeutics's official website?

Fovero Therapeutics's official website is www.foverotherapeutics.com.au

Q: What is Fovero Therapeutics's Revenue?

Fovero Therapeutics's revenue is <$5 Million

Q: What is Fovero Therapeutics's SIC code?

Fovero Therapeutics's SIC: 87,873

Q: What is Fovero Therapeutics's NAICS code?

Fovero Therapeutics's NAICS: 54,541

Q: How many employees does Fovero Therapeutics have?

Fovero Therapeutics has 1-10 employees

Q: What industry does Fovero Therapeutics belong to?

Fovero Therapeutics is in the industry of: Business Services , Research & Development

Q: What does Fovero Therapeutics do?

Fovero Therapeutics is an Australian biotechnology company specializing in the development of novel immunotherapies for patients with immuno-oncology resistant cancers. The company utilizes its proprietary Galectin-9 platform to enhance immune regulation in solid tumors, particularly targeting dysregulated immune functions that are common in malari... a, cancer, and autoimmune diseases. Their lead antibody has demonstrated significant efficacy in pre-clinical models, showing the potential to completely control certain types of cancer. Fovero Therapeutics aims to transform patient care with innovative solutions that differ from traditional immune-oncology therapies. Read More

Q: Is Fovero Therapeutics a public company?

Fovero Therapeutics is private company therefore does not currently have an official ticker symbol

Business Services · Australia · 1-10 Employees

View Company Info for Free

Overview

Headquarters

300 Herston Rd, Herston, Queensland, 400...

Website

www.foverotherapeutics.com.au

Revenue

<$5 Million

Industry

Business Services

Research & Development

ZI Rank: 1

Signal Type

Feb

Mar

Apr

May

Jun

Jul

ZI Rank

About Fovero Therapeutics

Fovero Therapeutics is an Australian biotechnology company specializing in the development of novel immunotherapies for patients with immuno-oncology resistant cancers. The company utilizes its proprietary Galectin-9 platform to enhance immune regulation in solid tumors, particularly targeting dysregulated immune functions that are common in malaria, cancer, and autoimmune diseases. Their lead antibody has demonstrated significant efficacy in pre-clinical models, showing the potential to completely control certain types of cancer. Fovero Therapeutics aims to transform patient care with innovative solutions that differ from traditional immune-oncology therapies.Explore more

Is this data correct?

View contact profiles from Fovero Therapeutics

Popular SearchesFovero TherapeuticsSIC Code 87,873NAICS Code 54,541Show more

Fovero Therapeutics Org Chart

Phone

Michelle Wykes

Founder & Chief Scientific Officer

Phone

Get the full picture

Is Fovero Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Congratulate Masked Content for being promoted to Masked Content at Fovero Therapeutics

Fovero Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic

Earning: See what the market has to say on Fovero Therapeutics recently announced quarterly report

Check out if Fovero Therapeutics is spiking on competitors!

Website visits: Recent activity has been detected on your website

Product Launch: Get notified when Fovero Therapeutics launches new products

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Check if Fovero Therapeutics has recently received funding, and reach out quickly before it becomes old news!

Click to see if Fovero Therapeutics had a recent Job posting/layoffs

Funding: Get notified immidiatlly once Fovero Therapeutics has new funding data

Recommended Actions

Introduce yourself to Masked Content, who has shown a strong intent to purchase lately

Find 3 more new buyers

View Email Formats for Fovero Therapeutics

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Fovero Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Fovero Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Fovero Therapeutics.